ERSP Finds M&M, Inc. Can Support Certain Claims For “Flex Belt”, Marketer Discontinues Certain Claims

New  York,  NY  –  May  27,  2011   –  The  Electronic  Retailing  Self-Regulation  Program  has determined that M&M, Inc. has provided adequate support for performance claims made in direct response advertising for the Flex Belt. The marketer voluntarily discontinued several other claims that were the subject of the ERSP inquiry.

ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

The marketer’s advertising came to the attention of ERSP pursuant to its ongoing self- monitoring program.

ERSP reviewed broadcast and online advertising for the Flex Belt, and identified several claims for review, including:

  • “The Flex Belt easily tightens, tones, and firms abdominal muscles.”
    • “Flex Belt’s advanced electronic muscle stimulation basically does all the work for you.”
    • “Wearing it is all you have to do to get results, demonstrated results in just 6 weeks.”
  • “Safe, sensible and FDA cleared.”
    • “As a result, you get an effective abdominal workout that targets all the muscles in your abdomen – all in just 30 minutes a day.”
    • “The Flex Belt will stimulate all your stomach muscles causing contractions that provide you with the perfect crunch – that means your upper abs, the lower abs an even your obliques are going to get worked from The Flex Belt…and it does all the work for you.”
  • “Used daily you should see results in 4-8 weeks.”
  • “Demonstrated Study Results You Can FEEL In Just Weeks.”
    • “We saw a 49% increase in abdominal strength and 72% increase in abdominal endurance which are phenomenal results.”
    • “One of the things I noticed right away was the strength of the contraction I got versus some of the other machines.” [John P. Porcari]

 

ERSP also reviewed claims included in consumer testimonials, including:

  • “I use the Flex Belt for my abs. There are a lot of other products, but they can’t beat the Flex Belt for effectiveness.” [Janet Evans]
  • “I’ve lost 15 lbs and my stomach muscles are rock hard…” [Casey C.]
    • “I lost about 3 inches in my stomach area in less than 2 months, and I am sure I will loose more, the more I use the belt.” [Nazek S.]
  • “My waist lost three inches in three weeks.” [Ross C.]
  • “It’s now May and I have already lost 4 inches off my waist and 15 lbs total.” [Kasha J.]

 

At the outset, M&M, Inc. informed ERSP that the Flex Belt is manufactured by Bio-Medical Research, Ltd., which also makes the Slendertone line of abdominal belts, a product whose advertising was reviewed by ERSP in 2005. The marketer explained that the two products are considered the same for safety and efficacy purposes by the FDA and thus, research conducted on the Slendertone belt is applicable to the Flex Belt.

 

M&M,  Inc. provided  ERSP  with  several studies  demonstrating  the effectiveness  of  the Slendertone belt in improving abdominal strength and endurance. ERSP determined that this information provided a reasonable basis for the performance and establishment claims made in direct response advertising for the Flex Belt.

The marketer also informed ERSP that it would voluntarily remove consumer testimonials that include express claims of inch loss, weight loss, and six-pack ab-type statements. Additionally, M&M, Inc. agreed to remove Janet Evans’ testimonial (i.e., “I use the Flex Belt for my abs.  There are a lot of other products, but they can’t beat the Flex Belt for effectiveness”).

The company, in its advertiser’s statement said, “M&M, Inc., is pleased to have participated in the ERSP process … M&M recognizes and appreciates ERSP’s rationale with regard to those modifications made to the website and will consider them when developing future advertising content.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary